Filing Details
- Accession Number:
- 0001209191-22-059881
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-12-05 19:49:20
- Reporting Period:
- 2022-12-01
- Accepted Time:
- 2022-12-05 19:49:20
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1750019 | Tcr2 Therapeutics Inc. | TCRR | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1556064 | E Garry Menzel | C/O Tcr2 Therapeutics 100 Binney Street Cambridge MA 02142 | President & Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2022-12-01 | 221,058 | $0.00 | 221,058 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2022-12-02 | 8,408 | $1.39 | 212,650 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Restricted Stock Unit | Acquisiton | 2022-12-01 | 158,795 | $0.00 | 158,795 | $0.00 |
| Common Stock | Restricted Stock Unit | Acquisiton | 2022-12-01 | 40,881 | $0.00 | 40,881 | $0.00 |
| Common Stock | Restricted Stock Unit | Acquisiton | 2022-12-01 | 21,382 | $0.00 | 21,382 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 3,241 | No | 4 | M | Direct | ||
| 15,120 | No | 4 | M | Direct | ||
| 23,165 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 132,729 | Indirect | See Footnote |
| Common Stock | 132,730 | Indirect | See Footnote |
Footnotes
- Consists of 132,729 shares of common stock held by the Garry E. Menzel and Mary E. Henshall Family Trust, under instrument of trust dated July 29, 2010, to the Garry E. Menzel Revocable Trust of 2022, under Indenture of Trust dated April 5, 2022 (the "Menzel Trust"). The reporting person is the trustee of the Menzel Trust, and as such the reporting person may be deemed to beneficially own such securities. The reporting person and members of his immediate family are the sole beneficiaries of the Menzel Trust.
- Consists of 132,730 shares of common stock held by and the Mary E. Henshall Revocable Trust of 2022, under Indenture of Trust dated April 5, 2022 (the "Henshall Trust"). The reporting person's spouse is the trustee of the Henshall Trust, and as such the reporting person may be deemed to beneficially own such securities. The reporting person and members of his immediate family are the sole beneficiaries of the Henshall Trust.
- Represents the the aggregate number of common stock converted from restricted stock units granted to the reporting person on 11/17/2022 pursuant to the issuer's offer to exchange eligible options for new restricted stock units program.
- Each restricted stock unit represents a right to receive one share of the issuer's common stock at the time of vesting for no consideration.
- The sales reported represent the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. These sales were automatic and intended to qualify under Rule 10b5-1.
- 98% of these restricted stock units vested on December 1, 2022, and the remaining 2% will vest on December 1, 2023.
- 73% of these restricted stock units vested on December 1, 2022, 25% will vest on December 1, 2023 and the remaining 2% will vest on December 1, 2024.
- 48% of these restricted stock units vested on December 1, 2022, 25% will vest on December 1, 2023, another 25% will vest on December 1, 2024 and the remaining 2% will vest on December 1, 2025.
Billionaire Hedge Funds
